Case study suggests medical cannabis as option for pain management in Fabry.
A man with Fabry disease experienced an easing of neuropathic pain, or nerve pain, with medical cannabis after failing to respond to standard therapies, a case study reports.
“A clinical trial, including more patients, is needed to establish efficacy and safety of this analgesic approach in patients with FD [Fabry disease] and neuropathic pain,” researchers wrote in the study “Relief of nocturnal neuropathic pain with the use of cannabis in a patient with Fabry disease,” which was published in the journal Molecular Genetics and Metabolism Reports.
– Read the entire article at Fabry Disease News.
